港股異動 | 多重利好疊加 中海油(0883.HK)續升近6% 市值重回4000億港元
格隆匯9月28日丨中海油(0883.HK)延續漲勢,再度拉昇漲近6%,4日累計漲幅達15%。現報8.97港元創3個月新高價,總市值重回4000億港元上方。公司日前公佈計劃回到上海證券交易所進行A股IPO計劃。此次“回A”將使中海油在維持其國際發展戰略的同時,能完善資本架構,有助於提升公司企業形象、更好地滿足公司資本支出的需求、拓寬融資渠道、改善公司的資本結構。大和指出,中海油發行A股有望利好氣氛,集資有望增快產量增長,重申跑贏大市評級。此外,高盛表示,當前的石油供需缺口超乎想象,上調2021年年底布倫特原油價格預期10美元至90美元/桶。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.